MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/25/2026

1. NVDA
2. SPY
3. AAPL
4. XPEV
5. DKS
6. USO
7. BMO
8. VEEV
9. GRML
10. AMD

Go back to MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
MACROGENICS (NASDAQ: MGNX) Delayed: 4.17 +0.15 (3.73%)
Previous Close $4.02    52 Week High $36.11 
Open $4.04    52 Week Low $14.84 
Day High $4.20    P/E 10.69 
Day Low $4.04    EPS $0.39 
Volume 363,137